Response to Ramaekers: Pitfalls in estimating drug-related crash risk
- 作者F Javier Álvarez; M Carmen Del Rı́o
- 卷第24卷
- 期第3期
- 印刷ISSN0165-6147
- 文件大小42.97KB
- 发表时间2003
- DOI10.1016/s0165-6147(03)00029-4
Statins and myotoxicityJohn A. Farmer · 2003
Statins and myotoxicity: a therapeutic limitationTiwari, Atul; Bansal, Vinay; Chugh, Anita; Mookhtiar, Kasim · Expert Opinion on Drug Safety · 2006
Statin-Induced Myotoxicity: Pharmacokinetic Differences among Statins and the Risk of Rhabdomyolysis, with Particular Reference to PitavastatinL. Catapano, Alberico · Current Vascular Pharmacology · 2012
Statins and Myotoxic Effects Associated With Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase AutoantibodiesWatanabe, Yurika; Suzuki, Shigeaki; Nishimura, Hiroaki; Murata, Ken-ya; Kurashige, Takashi; Ikawa, Masamichi; Asahi, Masaru; Konishi, Hirofumi; Mitsuma, Satsuki; Kawabata, Satoshi; Suzuki, Norihiro; Nishino, Ichizo · Medicine · 2015
Statins and PPARα agonists induce myotoxicity in differentiated rat skeletal muscle cultures but do not exhibit synergy with co-treatmentTimothy E. Johnson; Xiaohua Zhang; Shu Shi; Diane R. Umbenhauer · 2005